Search Results 1601-1610 of 16378 for Maximum

  1. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    The purpose of this study is to characterize the safety and tolerability of combined treatment with mogamulizumab and nivolumab, and also determine the maximum ...

  2. Neurosciences Clinical Trials - Medical Professionals

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  3. A Study of TRK-950 in Patients With Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and the dose limiting toxicities (DLTs) of TRK-950 as single agent and to ...

  4. A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer - Mayo Clinic

    * Maximum time allowed between definitive therapy completion and randomization must be: * 10 weeks if no chemotherapy was administered * 26 weeks if ...

  5. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been Removed by Surgery - Mayo Clinic

    ... maximum size requirements. All standard tumor-staging procedures necessary to define baseline extracranial disease status completed ≤ 42 days prior to pre ...

  6. J-1 Visa - Immigration and Visas - Mayo Clinic College of Medicine & Science

    Time spent in your previous program(s) prior to the transfer will be counted toward the maximum stay allowed. If you wish to transfer your J-1 status from ...

  7. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

    No mediastinal mass >0.33 maximum intrathoracic diameter on chest x-ray (see Appendix B); No adenopathy ≥7.5 cm in its largest diameter. Measurable disease ...

  8. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + vinblastine for ...

  9. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

    ... maximum tolerated dose (MTD). In addition, this study will also assess the pharmacokinetic (PK) profile and preliminary efficacy of SBP-101. Participation ...

  10. Hyperthyroidism - Diagnosis and treatment - Mayo Clinic

    The most likely cause is either Graves' disease or overactive thyroid nodules. If your thyroid gland takes in a low amount of radioiodine, that means hormones ...